Skip to content
Markets News
Stocks1 min read

Missouri Court Clears Bayer’s Roundup Claims Settlement

Makkler Newsroom
November 21, 2026 · Based on reporting by The Guardian, NOS, tagesschau

The judge approved a deal worth up to $7.25 billion, intended to compensate current and future claimants alleging Roundup-related cancer.

Key takeaways

  • A Missouri judge approved Bayer’s settlement worth up to $7.25 billion.
  • The agreement covers claims alleging Roundup caused non-Hodgkin lymphoma, including future diagnoses.
  • Some federal lawsuits remain outside the settlement.

A Missouri judge approved Bayer’s settlement worth up to $7.25 billion over claims that its Roundup weedkiller caused cancer. The agreement is intended to compensate tens of thousands of people who allege they developed non-Hodgkin lymphoma after using the product.

The deal, negotiated in February, covers current and future claims and provides for payments over as long as 21 years, according to tagesschau. Judge Timothy Boyer called it “fair, reasonable and adequate” and rejected objections that some claimants’ payments would be too low.

Bayer said the approval was a milestone in its effort to limit pending and future litigation. The company has maintained that glyphosate, Roundup’s active ingredient, does not cause cancer; tagesschau reported that the settlement does not include an admission of liability.

The settlement does not cover some lawsuits still pending in federal court. Bayer said about 200 such cases remained under litigation, while a US Supreme Court decision narrowed claims based on alleged failures to warn about cancer risks.

Topics
BAYNRoundupMonsanto

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.